This study is in progress, not accepting new patients
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Galapagos NV
- ID
- NCT02914561
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- At least 1374 people participating
- Last Updated